
TB-500 (5 mg) + BPC-157 (5 mg) Stack5 mg + 5 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
TB-500 (5 mg) + BPC-157 (5 mg) Stack, explained simply
Two separate vials representing two experimental lines of tissue research, without dedicated clinical evidence for the combination.
Research area
Stacking and recovery
How it works
This stack uses separate TB-500 and BPC-157 vials, each discussed in research on tissue responses.
Why it matters
Keeping them separate makes differences in mechanism and evidence clearer.
What has been observed
Observations chiefly concern the individual peptides; their research programs remain distinct.
Effects and points to consider
Synergy and safety of the combination have not been established by dedicated clinical studies.
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Separate vials | TB-500: 5 mg; 2 mL; 2.5 mg/mL | BPC-157: 5 mg; 2 mL; 2.5 mg/mL |
|---|---|
| Page cycle context | 8-16 weeks |
TB-500 Protocol (2 mL Reconstitution = 2.5 mg/mL)
| Week | Dose (mcg) | Units (per injection) (mL) | Frequency |
|---|---|---|---|
| Weeks 1–4 | 1,250 mcg (1.25 mg) | 50 units (0.50 mL) | Twice weekly |
| Weeks 5–12 | 1,250 mcg (1.25 mg) | 50 units (0.50 mL) | Once weekly |
BPC-157 Protocol (2 mL Reconstitution = 2.5 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) | Frequency |
|---|---|---|---|
| Weeks 1–2 | 250 mcg (0.25 mg) | 10 units (0.10 mL) | Once daily |
| Weeks 3–8 | 500 mcg (0.50 mg) | 20 units (0.20 mL) | Once daily |
| Weeks 9–12 | 250 mcg (0.25 mg) | 10 units (0.10 mL) | Once daily |
Supplies needed


Sterile alcohol swabs
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.